Other Controls and Reagents
Medchemexpress LLC 1-Palmitoyl-sn-glycero-3-phosphocholine-d49 | 2315262-40-7 | >99.0% | 544.93 | C24HD49NO7P | 1MG
1-Palmitoyl-sn-glycero-3-phosphocholine-d49 is the deuterium-labeled isotopologue of 1-palmitoyl-sn-glycero-3-phosphocholine (16:0 Lyso PC). Supplied as a solid, it is used as an analytical reference and internal standard in lipidomics and mass spectrometry workflows to enable accurate quantitation of lysophosphatidylcholine species.
- Isotopically labeled with 49 deuterium atoms (d49).
- Chemical formula C24HD49NO7P.
- Molecular weight 544.93.
- CAS number 2315262-40-7.
- Supplied as a solid in small pack sizes, suitable for analytical use.
- Intended for use as an internal standard in LC-MS/MS and lipid analysis.
Cayman Chemical 1 2-DIoleoyl-sn-glycerol 25mg
An analog of the PKC-activating second messengers collectively called DAG; equipotent to 1,2-dioctanoyl-sn-glycerol in induction of the acrosome reaction in human sperm
Cayman Chemical DLIn-KC2-DMA 10mg
An ionizable cationic lipid (pKa = 6.7); has been used in the formation of LNPs encapsulating siRNA or plasmid DNA for use in vitro and in vivo; LNPs containing DLin-KC2-DMA selectively accumulate in the liver after i.v. or i.m. administration in mice or localize to the retinal pigment epithelium and Müller glia after subretinal administration; DLin-KC2-DMA-containing LNPs encapsulating F7-targeted siRNA reduce serum Factor VII levels in mice; DLin-KC2-DMA-containing LNPs encapsulating AR-targeted siRNA decrease serum PSA and tumor androgen receptor levels in an LNCaP prostate cancer mouse xenograft model
Cayman Chemical DLIn-MC3-DMA 100mg
An ionizable cationic lipid (apparent pKa = 6.44); has been used in the generation of lipid nanoparticles (LNPs) encapsulating siRNA, mRNA, or plasmid DNA for use in vitro and in vivo; LNPs containing DLin-MC3-DMA accumulate in the muscle and non-draining lymph nodes after intramuscular administration and in the spleen after intravenous administration in mice; LNPs containing DLin-MC3-DMA and encapsulating F7 siRNA reduce hepatic and plasma Factor VII levels in mice without inducing liver toxicity
eMolecules D-Lin-MC3-DMA | Broadpharm | 1224606-06-7 | | 642.110 | C43H79NO2 | 97.000 | CCCCC\C=C/C\C=C/CCCCCCCCC(CCCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCN(C)C | 100mg | 599128531
D-Lin-MC3-DMA | Broadpharm | 1224606-06-7 | | 642.110 | C43H79NO2 | 97.000 | CCCCC\C=C/C\C=C/CCCCCCCCC(CCCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCN(C)C | 100mg | 599128531
Cayman Chemical 1 3DIstearoyl2oloyl Glyce 25mg
A triacylglycerol; has been found in Kpangnana, Chinese tallow, and cocoa butters; increases the phagocytic function of reticulo-endothelial cells in mice at 5 and 10 mg per animal
Avanti Polar Lipids C18:1 Glucosyl(ß) Ceramide, 5 mg, Powder, C42H79NO8, Glycosphingolipid, Ceramide, 726.079 g/mol, β-1,1' Glucosyl Linkage, 9Z-octadecenoyl (Oleoyl)
C18:1 Glucosyl(ß) Ceramide (d18:1/18:1(9Z)) is a high-purity glycosphingolipid from Avanti Polar Lipids. This ceramide consists of an oleoyl fatty acid chain and a D-erythro-sphingosine base, and is available in a 5 mg quantity. The empirical formula is C42H79NO8, with a molecular weight of 726.079, making it valuable for lipid biology research.
- High-purity glycosphingolipid
- Available in 5 mg quantity
- Empirical formula: C42H79NO8
- Molecular weight: 726.079
- Lipid class: Glycosphingolipid, Ceramide
- Fatty acid: 9Z-octadecenoyl (Oleoyl)
- Sphingoid base: D-erythro-sphingosine (d18:1)
- Physical form: Powder
![Avanti Polar Lipids 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt), 474922-77-5, MFCD02262268, 25 mg](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00037649-C2618-200UL.PNG-250.jpg)
Avanti Polar Lipids 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt), 474922-77-5, MFCD02262268, 25 mg
Formula Weight: 2805.497, Purity >99%, Storage Temperature: -20°C. PEG-modified lipids are typically added to phospholipid vesicles used for drug delivery to provide a steric coating on the surface of the membrane to hinder clearing of the particles by the reticuloendothelial system (RES). This prolongs the circulating plasma half-life of the drug. The plasma half-life of the drug can be "tuned" from several hours to days depending on the size of the PEG and fatty acids attached to the lipid anchor.
![eMolecules Broadpharm / 181 TAP (DOTAP MS Salt) / 10mg / 718091881 / BP-28291 / 95.000 / 144189-73-1 / [null] / 663.104 / C42H80NO4](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502469549.JPG-250.jpg)
eMolecules Broadpharm / 181 TAP (DOTAP MS Salt) / 10mg / 718091881 / BP-28291 / 95.000 / 144189-73-1 / [null] / 663.104 / C42H80NO4
Broadpharm / 181 TAP (DOTAP MS Salt) / 10mg / 718091881 / BP-28291 / 95.000 / 144189-73-1 / [null] / 663.104 / C42H80NO4